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Abstract
Background: Implementation of antiretroviral treatment in Ethiopia has offered to those who
accessed to the service priceless changes in terms of individual health, socially,
psychologically and comfort for the families and communities at large. However,
besides the targeted outcome, some unexpected problems can occur during rendering
such massive service because of different reasons resulting in poor quality of the
service. Thus the need for assessing complete patient records and ART response for
proper monitoring, among others, is undoubtful.
Objectives: To assess overall record completeness, proportion of those with CD4 cell count
determined and the ART response.
Methods: The study method is retrospective medical follow up based on data review of patients’
records on ART in Zawditu Memorial Hospital. All records of those patients
registered in the clinic between September 2006 and August 2007 were used for the
purpose. The data recorded in the patients’ files, the proportion of those whose CD4
cell count was determined, and the response of the ART among those who had
complete CD4 cell determination were assessed. Various statistical techniques were
used for data analysis and interpretations. The perspectives of health care providers
at the site were assessed using a closed ended questionnaire.
Results:  A total of 1561 medical records of ART patients were reviewed for data. The mean age
of the subjects was 35.6 years. The majority of the medical files, ranging between
o.1% (ARV drugs) and 98.6% (income status) were incomplete. The mean CD4 cell
count for those who had complete record was 126(SD=+/-83.2), 231(SD=+/-125.7)
and 266 (SD=+/-143.3) cells/µL at initiation, six and twelve months which is
statistically significant increment.
Conclusion and Recommendations:  The finding of the study showed increase in unrecorded
data with increasing follow up time for most of the repeatedly determined variables. The overall
response of patients on ART as measured by CD4 cells count at different points was found to be
significant. Improving record keeping and periodic analysis of routine ART data need to be done
to properly monitor the ART program.
vii
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I.    Introduction
The purpose of this study initially was to assess the ART response among adult patients on ART
in Zawditu Memorial Hospital ART clinic. A one year short review of CD4 cell count pattern was
checked before the start of the study. The review showed significant missing CD4 cell count.
Because of this observation the title of the study was made to include the data completeness to see
into the gap, with initial idea of assessing ART response. The two areas are now assessed together
until they are seen separately in the future by interested researchers in a larger scale.
To achieve quality health service, the input, process and outcome of health care system must
involve every department and every health worker. Building quality health service design in the
first place, helps assuring and maintaining it through monitoring and control activities, in other
words, quality health service should have capacity building and training, standardization, quality
design, monitoring, improvement of the services and documentations (1).
The Government of Ethiopia issued the National Policy on HIV/ AIDS in 1998 to mitigate
the impact of HIV/ AIDS, to coordinate all activates that are taken in this area and to prevent the
transmission of the epidemic nationwide (2). The National HIV/ AIDS Prevention and Control
Office were established to coordinate and work closely with Federal Ministry of Health addressing
the epidemic. Along with this guideline, various interventions (VCT, PMTCT, PICT and ART)
have been prepared and distributed. Training of health professionals for the purpose of HIV
prevention and intervention was carried out and antiretroviral drugs availability, laboratory with
necessarily equipments, machines and reagents were made ready. Mechanisms of monitoring and
evaluation were developed (3). The National ART Strategic Communication Framework, with
purpose of guiding and supporting ART communication activities in Ethiopia has been established
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as key element of the framework, research, monitoring and evaluation with perspective of
including process indicators and impact indicators, to effectively measure ART interventions (4).
The use of combined antiretroviral drugs in management of HIV- infected patients, known as
highly active antiretroviral therapy (HAART) was introduced in developed world in 1996 (5).
By the year 2003 it was gradually channeled to developing world. It has been found to be effective
in control of viral replication, thus minimizing the damage made to human health. Although there
is no cure; it has helped in reconstituting and strengthening immune system and enabling it to fight
against opportunistic infections. HAART has, therefore, significantly decreased morbidity and
mortality caused by HIV (6).The effect of HAART on HIV is known to be antiretroviral therapy
(ART) response. This response depends not only on antiretroviral drugs, but also on the quality of
ART service as a whole. However, the ART response, as end outcome can be measured by using
standardized relatively inexpensive assays. Currently, plasma HIV-RNA and peripheral CD4 cell
counts are taken as principal surrogate markers for HIV progression in clinical practice. WHO
recommends the use of total lymphocyte count (TLC) below 1200/ mm3 as cut off point for ART
initiation in poor settings, besides clinical condition and stage of the disease. Recently CD4 cells
count of <200 cells/ µl is used for the purpose by resource limited countries supported by
International partners (7, 8).
Ethiopia introduced antiretroviral therapy (HAART) in July 2003. So far 132,865 HIV/ AIDS
patients have been on HAART up to March 2009, still on follow up, including children. The
number of people currently living with HIV/ AIDS is estimated to be 977,394, including the
children whose number is 64,813. Out of these 258,264 need antiretroviral treatment, children
making, 6% or 15,716. So, only slightly more than 50% of those who need ART are on the
treatment. In Addis Ababa the number of HIV/AIDS patients ever started on ART (in public and
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private health institutions at 53 ART sites) is 50,705 among whom only 36,835 are retained. In
ZMH 8,875 patients were ever started but the number of those still on ART is 5396, which is the
biggest number of ART clients in one centre in the country (2, 5, 16, 17).
The process of antiretroviral treatment can face problems that occur during the activities of the
service, particularly in terms of recording clinical and laboratory data.  The structure and quality
of medical records has been a matter of clinical, administrative and legal interest for many years.
Medical records are now used not only for the primary, but also for secondary clinical purposes
including reporting the activities of hospital services monitoring their performances and for
research. Currently standardization of medical records has become a necessity. Besides the generic
medical record keeping standards, electronic medical recording has been implemented in medical
services (9). Proper record keeping is useful tool also for historical records, communication among
health providers, anticipation of future health problems and identifying deviation from expected.
In this regard all health professionals and administrative staff are supposed to keep records (10,
11).
Ever since the implementation of HAART in Ethiopia, there have been few studies conducted on
assessment of ART patients’ record keeping and changes in CD4 cell counts among patients on
ART (12). Antiretroviral therapy service has been first started in Zawditu Memorial Hospital,
Addis Ababa; Selected as Center of Excellence for ART, then gradually decentralized to other
Governmental and Private Hospitals and to Health Centers. Following ART scale-up and service
decentralization, several issues related to ART Implementation in Addis Ababa; monitoring,
evaluation and operational research are believed to make the ART program successful (13).
This study assesses the ART service in terms of medical data recording and record keeping
practice, outcome and factors that determine the outcome in the model ART clinic. The findings of
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the study; be it weakness or success, may not be representative as it is carried out  in  one center ,
but can serve as starting piece of information to take timely corrective actions by mobilizing
human and material resources, strengthen areas of success and run large scale or representative
research projects by Addis Ababa Regional Health Bureau , partners working in support of the
ART program in the capital city or any other interested body in this area in the future.
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II     Literature Review
The International Communities have been exerting the maximum efforts to halt the rapid
transmission of HIV infection and to mitigate its impact worldwide. Although some signs of
stabilizations have been achieved in some countries, the incidence of HIV infection is still
increasing especially in most of the developing countries. The world still hosts over 33.2 million
people living with HIV/AIDS. New incidence of infection is 2.5 million annually. Sub – Saharan
countries taking about 68% of it. So the need for concerted efforts to control the pandemic
continues to be the first in the list of health issues globally (14, !5).
Currently there are 420 treatment operational sites in Ethiopia. Out of these 368 are reporting
monthly updates (16, 17). ART scale–up has been carried out by Ethiopian Government
(FMOH/FHAPCO), Partners (CDC Ethiopia, John Hopkins University) and others International
Organizations. Sizeable progress has been achieved. Activities of issuing and updating guidelines,
strategies, etc. to harmonize and standardize, the antiretroviral therapy in all accredited ART
service sites all over the country, including Addis Ababa have been undertaken (9,12). Problems
are expected to occur in such massive service provision program, specially, to live up to the
expected quality of antiretroviral treatment outcome becomes difficult (4, 18).
Antiretroviral therapy must have well defined features and steps to ensure the quality of clinical
service delivery. A national organizing body develops the accreditation criteria for clinical centers
that would be authorized to prescribe antiretroviral drugs. Minimum criteria for a health facility to
be accredited include: setting and achieving targets for the comprehensive basic health care
services, presence of basic physical infrastructure, (space for HIV counseling and testing clinical
assessment, drug storage, laboratory), availability of drugs, reagents, equipments, IEC materials
and minimum number of qualified personnel with experience in HIV/AIDS management and the
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ability to ensure the provision of follow-up care and support for the families and communities with
PLWHA (19).
A. Record keeping
Among the possible problems encountered during large scale ART services, incomplete medical
recording is likely to be the important one. Complete patient records can simplify the future plan
for each patient by health providers, including when there is takeover of cases among the
providers. Monitoring of the ART service activities in site facilities depend on the data that are
recorded properly on daily basis in patients’ files, record books, admission and discharge books,
etc. Future plans of action to correct or strengthen and support the ART activities rely on the
medical data recording and record keeping (9,10, 12).
Medical data are supposed to be completed in the files of ART clients by registration clerks,
nurses, clinicians and others with ART related activities (counselors). Several forms are used for
data recording starting from reception to exit at pharmacy out let. To improve the process of data
recording and record keeping, the data registration clerks have the responsibility to check that the
data are complete; if not they are supposed return the files with respective forms to the respective
health care provider in ART service for completing the missing data (20).
Some studies conducted in resource limited countries using centralized electronic database for data
recording and record keeping have shown encouraging results. Zambian study on ART record
keeping using home-based-care (HBC) workers for ART data collecting and reporting to a
nongovernmental organization which introduced standardized centralized database is one good
example in achieving in a better patient care and analyzing the trend of patient status in time
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In 15 countries of Africa, South America and Asia a survey was carried out on the use of
electronic medical record system in ART programs in which 15(83%) sites used personal soft
ware, Median percentage of missing data for key variables per site was 10.9% which declined with
training in data management and weekly hours spent by a clerk on the database per 100 patients on
ART to below 10% (22).The heavy work load on already limited number of health care providers
threatens the quality of ART service. Data management and record keeping become poor. In study
conducted on dropouts of ART patients, a large number of missing data on clinical patient
variables was observed which was partly explained by the high work load of the clinical staff with
lack of a user-friendly system for recording adverse events (23).
Recently a study conducted in Malawi to assess the quality and accuracy of the ART facilities by
comparing the site report and the supervision report, using key case registration and outcome
variables; the data completeness given by site report resulted in a 12% undercount of the national
total number of persons on first-line antiretroviral treatment indicating that the site report was
inadequate for monitoring the ART service activities (24).
In another study conducted in South Africa on a large public programme to prevent Mother-to-
Child HIV transmission, it was found that data completeness reported over 12 months was only
half (50.3%) and data accuracy for six selected elements studied were missing from the clinics’
registrar between 4.5% and 41%, data missing from  the DHIS  were between 29.2% and 87.1%.
Under such circumstances it will be difficult for national health programming in developing
countries to depend on for disease or programme surveillance (25).
In developed countries, to decrease such data incompleteness, standardized computer-based
patient recordings have been implemented routinely. A study conducted in USA showed that the
electronic recordings have more complete documentations with appropriate clinical measures than
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generic paper records. However, the use of this technology in resource limited countries remains
remote though few have been trying to do so (26).
B.1.The HIV Infection and CD4 Cells
As the HIV Virus enters the human body, it kills the CD4 cells massively and replicates
exponentially during the first few weeks or months. Wide dissemination of it without any
opposition takes place with seeding of lymphoid organs. The number of CD4 cells (T-
lymphocytes) declines while viremia increases. When the body somewhat, develops immune
response, the viremia starts to decrease and the CD4 cells number increases to some extent. The
viremia decreases and relatively long time stabilization takes place although slow damage to the
immune system by the HIV-Virus continues. This prolonged destruction of the immune system
ultimately results in further reduction of CD4 cells, exposing the body for opportunistic infections.
So, there is a relation between HIV/Virus replication and low CD4 cells in a reciprocal manner.
This relation, therefore, makes the CD4 cell count the most important marker of the immune
deficiency status and measuring of it universally (27, 28).
B.2. Antiretroviral therapy and CD4 cells count
Based on the, eligibility of the patients HAART is initiated. WHO recommends combination of
two antiretroviral drugs from nucleoside reverse transcriptase inhibitors (NRIT) and one
antiretroviral drug from non–nucleoside reverse transcriptase inhibitors (NNRTI) or three of
ARVs from NRTI class as the first line HIV/AIDS treatment or protease inhibiters combined with
NRTIs or NNRTIs, as second line ARVs. The selection of drugs depends on several factors related
to the patients’ conditions (12).
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In most patients CD4 cells rise with the initiation of HAART, although immune recovery in some
is not significant. However, an average of 100 cells/µL increase takes place per year.
Determination of CD4 cells count is done at initiation as baseline, and every three to four months
in treated patients; three to six months for untreated patients (29). In resource limited settings,
CD4 cell count can be determined  at initiation of ART, at 6 months and 12 months. Viral load
determination is not practiced for the same reason. The HAART has been found to be effective
and it decreases the level of the virus to undetectable level with few weeks after its initiation and
the immune recovery takes place. But it does not eliminate the virus totally from the body of the
patients. Accumulated evidence suggests that the rate of CD4 cells response to HAART is of a
pivotal importance as a predictor of clinical outcome (30).
In a study conducted on 288 ARV – naïve patients in khayelitsha, South Africa, one year after
initiation of ARV drugs, the majority of them had mean body weight gain of 10 kilograms and
83% of them had undetectable level of viral load; and mean CD4 cell count of 221 /micro liter
with proportion of surviving of 84% (31, 32). Another South African study conducted on a cohort
with baseline CD4 cell counts less than 50 cells/µL showed equivalent or greater capacity for
immunological recovery during 48 weeks of ART compared to those with higher baseline CD4
cell count. However, their CD4 cell counts remain less than 200 cells /µL for a longer period
potentially increasing their risk of morbidity and mortality in the first year of ART (33).
Various clinical trials using different ARVs as backbone combining with first or second line ARV
drugs have been carried out by different researches. One prospective cohort study conducted in a
multicenter research (France, Canada and Australia) revealed that the effect of early initiation of
HAART on CD4 cells count and HIV- RNA viral load trends within 24 months of the onset of
acute retroviral syndrome, increases the CD4 cells count faster and decrease HIV-RNA faster. The
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earlier the initiating of HAART the faster the CD4 cells recovery, but the response at or beyond 24
months needs further study (34).
However, studies conducted in Italy and Brazil showed that though HAART in many of HIV
infected individuals have plasma HIV-RNA to undetectable level and increment of CD4 cells
overtime, but in a number of patients a discrepancy between plasma viral load and CD4 cells
recovery was observed. CD4 cells can rise despite persistently detectable plasma viral load
(Virologic non –responders) or conversely it does not increase despite full viral load suppression
(immunologic non-respondents). This defective immune reconstitution could be because of several
factors: previous therapeutic failure, duration of the HAART, low CD4 cell count at initiation, old
age, etc (35, 36).
In a European observational study on HIV positive patients who were on ART for 90 days and
made to interrupt ARVs for 14 days and resumed the treatment, the CD4 cells count was found to
increase less than in the first phase of the treatment, particularly in the elderly and in those with
low initial CD4 cells count. CD4-guided structured treatment interrupting on 329 cases randomly
divided into two groups; after four years of follow-up showed no significant advantage of either
continuous or interrupted treatment. However, the treatment interruption may be appropriate for
selected adults and children with HIV if CD4 cells count is maintained at high level. The two
studies were designed to develop new options or alternative treatment modalities that HIV patients
might practice in the future, to decrease poor adherence because of life- long treatment but it does
not seem that the purpose is successful and there is need to continue with other studies (37, 38).
Although the administration of antiretroviral drugs has generally positive effect in improving
clinical conditions and immune reconstitution of HIV/AIDS patients, it has also negative side
effect or adverse drug reactions (ADRs) which can interfere with patient compliance.In a study
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conducted to assess the prevalence of adverse drug reactions among HIV- infested adults on ART
and factors associated with it in Zawditu Memorial  Hospital Addis Ababa, anemia was found to
be the most frequently encountered ADR (33.9% followed by neuropathy (28.2% and elevated
ALT (25%). Rash was found to be low. It was noted that relatively high rate of changing of drugs
(22.8%) could be related to the high magnitude of ADRs encountered (39).
- The adverse drug reactions will result ultimately in poor adherence, which eventually gives
immunological, Virological or Clinical failure of antiretroviral therapy. Emergence of HIV-1
mutated strains resistant to one or more antiretroviral drugs is a leading cause of treatment failure
among patients on HAART. About 70% of treated individuals carry mutated variants of HIV-1
that are resistant to at least one antiretroviral drug. Transmission of mono or multi drug resistant
HIV-1 Viruses (MDR) is an area of concern in the provision of HAART. Cross – resistance is
frequent and the efficacy of the ARV drugs to which resistance had been developed will be short
(40).
- Underlying diseases or co-infections can enhance the viral replication and deterioration of the
effector cells (CD4 cells). A study conducted on HIV – infected with Hepatitis B virus infection
revealed that up to 10% of HIV – infected patients are found to be co-infected with hepatitis B
Virus (HBV) (41). Another study conducted in Ethiopia on 197 cases found that there was
significant sub-clinical hepatotoxicity (17.3%) of all patents and 8 of them (4.1%) developed
clinical hepatotoxicity. Seven of the 8 were HIV Positive while two of the 8 were positive for
Hepatitis B virus surface Antigen (HBsAg)(42).
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The rationale of the study
The ART clinic in Zawditu Memorial Hospital is the model centre to ever start providing the ART
service in the country since 2003. Out of 14,762 enrolled 8,875 were ever started on HAART
among whom 5396 are still on follow up which is a large number for one centre. Taking this into
consideration, it is expected to have wide experience in this area. The activities of this accredited
centre need to be assessed. However, the successes achieved or problems encountered have not
been evaluated so far.
The purpose of this study, therefore, is to assess the ART data recording and record keeping
practice of the centre, its determinants and the ART response. Measuring the quality of the service
can generate information that can serve for several purposes. Although being one site study limits
its representativeness, identifying areas of weaknesses can serve as a starting piece of useful
information to address the problems in time by responsible bodies to ensure and improve the ART
service delivery at the site by mobilizing available human and material resources accordingly.
Areas of success can be strengthened and maintained to help the national HIV infection
prevention program efforts. Aside from the above mentioned points, the information  generated
from this study can be a starting point for conducting a large scale or representative study to
further assess the extent of successes or problems encountered.
Assessment of Completeness of ART Patients’ Records and Changes in CD4 Cell Counts in Zewditu Memorial Hospital, Addis Ababa, Ethiopia 2009.
13
III. Objectives
1. General : To assess the of ART service record keeping practice and the ART response.
2. Specific:
 To assess ART record keeping practice.
 To describe the proportion of patients on ART whose CD4 cell count is
determined
 To determine the factors that influence the CD4 count completeness
 To assess the response of patients on ART among those whose data are
Complete.
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IV. Study Methods and Subjects(Materials)
4.1 Study Area
This study is conducted in Zawditu Memorial Hospital which is the first in the county to ever
start antiretroviral therapy (ART) as accredited public health institution. The ART Clinic of the
hospital is a model and Center of Excellence.
Zawditu Memorial Hospital is located at the heart of Addis Ababa and it is one of five
Hospitals under the Addis Ababa City Administration Health Bureau. It serves as a referral
hospital for catchment areas (sub cities) health centers, private clinics and hospitals. The activities
of the hospital depend on the budget allocated by Addis Ababa Health Bureau (AAHB), but some
technical and material assistance is secured from International Partners like CDC-Ethiopia, John
Hopkins University, and others for services related to HIV/AIDs.
There are well trained and experienced health professionals (physicians, nurses counselors,
laboratory technicians, and pharmacy technicians) in ART clinic, working full time. The ART
Clinic of Zawditu Memorial Hospital has been used, as it is relatively well organized, for ART
training (practical or clinical training) of health professionals, coming from all parts of the
country,
4.2. Study design
The study design is retrospective follow up focusing on the medical records of the patients on
ART. Closed ended questionnaire was used for the qualitative part of the study.
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4.3 Study Population:
The study is based on medical records of ART patients in Zawditu Memorial Hospital. All patients
registered from September 2006 to August 2007 for ART were included in the study. The health
care providers working in the ART clinic were included for the qualitative part of it.
A.  Inclusion criteria:- all adult AIDS patients with age above 15 years who had been registered
for antiretroviral therapy at ZMH ART unit between September 2006 –August 2007. The study
did not include pediatrics clients because the children’s ART clinic had just started the service and
no adequate number of cases was available in the respective year of the study.
B. Exclusion criteria: - All patients transferred in after having started the ART treatment
elsewhere before year the September 2006 – August 2007. This exclusion criterion was used to see
the ART response among patients who started in the same year because the response could be
different as number of years on ART increases and measuring the ART response in one year and
that of more than one year together using the same unit under the study design of one year may not
show clear outcome.
4.4 Sample size and sampling technique
All medical records initiated during September 2006-August 2007 were reviewed to determine
the data completeness based on the ART intake and follow up forms .A one year record was
reviewed without applying any sampling strategy.
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4.5   Data collection procedures (instruments, personnel, data quality and
control)
All patients referred to ART clinic are registered in either pre- ART or ART Register books. At
reception, ART nurses fill out the general or socio- demographic part of the HIV care or ART
clinic intake form. Then patients are sent for laboratory investigations (CD4 Cell count, blood
chemistry, routine investigations (hematology urinalysis, stool examination) X-ray examination
sputum exam .etc). The results are collected, attached to patients’ files and then the physicians and
ART prescriber nurses evaluate and make clinical decisions. The remaining part of the ART care
and follow-up forms will be completed by clinicians. Then the patients will be categorized into
pre-ART group or ART group based on their clinical findings. They will be started on HAART if
eligible, after counseling for ARVs given. (if needed, repeated on appointments, even by including
close relatives if patients can not take it) or followed –up on various prophylactic medications
until they are eligible.
The files of both groups are gathered on daily basis by data clerks and registered in pre-ART
log book or ART log book, where the unique numbers of the patients, date, month and year of
registration; laboratory results (CD4 and others) antiretroviral drugs etc. are recorded on the
respective register log books and entered into computers. Patients’ files are kept in the registry
according to the unique number order. The medical records of the study subjects among the ART
groups was reviewed for the data analysis of this study.
There are two physicians, three ART prescriber nurses and five ART nurses with VCT, ART,
and drug counseling /and adherence counseling/ training working currently in ZMH ART clinic.
Among them five (2 physicals and 3 ART nurses) were recruited and trained on study protocol
and data collection forms. Training was given for a day. A pre-test was carried out on randomly
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selected patients’ clinical records. The principal investigator was closely supervising the data
collectors on a daily basis. The data was collected using structured data collection form.
4.6 Variables
Dependent variables: Completeness of the records and CD4 cell count
Independent variables: socio demographic variables, b. Clinical condition at initiation of ART
(working, ambulating, bed-ridden -WAB), WHO stage of the disease and Laboratory
data (CD4, ALT/AST).
4.7 Definitions of terms
Adherence – in the context of antiretroviral therapy, it is the number of doses correctly taken by
A patient divided by the total doses prescribed for a given period of time. If the   patient takes
more than 95% of his prescribed drugs, adherence is considered as good otherwise fair or poor.
Adverse drug reaction effect (ADR) – unwanted and unintended effect caused by administration of
drugs (ARV drugs) with sudden or late onset.
Combination therapy – use of two or more ARV drugs to achieve maximum or optimal outcome
Opportunistic infections– infections with bacteria, fungi, viruses and protozoa that do not occur to
individuals with a normal immune system.
Resistance – When the sensitivity of HIV to a particular ARV drug is reduced, drug resistance can
be thought. It is usually related to genetic mutation.
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Quality ART service – one which has a minimum recommended package as per the national
standard and conducts recommended for service leading to meet the objectives set
up or expected results.
Accreditations – Evaluation of published standards in an organization by a multidisciplinary team
based on the specific environment in which the clinical care is delivered, (in this
context the ART service).
CD4 cell (T -cell) - CD4 (cluster differentiation 4) receptor used by HIV-1 to attaché on T cells.
The virus integrates into T-cells using the receptors (CD4) and kills them.
Therefore the CD4 represents the number of uninfected T-cells usually called by
health professionals “CD4 cell count”.
Complete record – A record is said to be complete if it contains all the essential information about
socio-demographic factors, clinical (WHO stage of the disease, functional status)
and laboratory data (ALT, AST, CD4 cell count, etc.) that are identified as the main
dependent and independent variables of this study.
4.8 Data processing and analysis
Processing: EPI- Info 3.3.2 was used for data entry and cleaning.
Analysis: The cleaned data were entered into SPSS statistical software version 15. The
frequencies of dependent and independent variables analyzed. Associations between factors
(dependent and independent variables) were tested using Odds Ratio (OD), Chi-square test for
linear trend, and multivariate statistical analysis.  For those having complete data; the mean
change in CD4 count was assessed using general linear model for repeated test to examine the
relationship between the dependent (CD4count) variable and independent variables to adjust the
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potential confounding variables and because of its ability to show the general pattern of the
repeatedly determined CD4 count and describe it in a concise way.
4.9 Ethical consideration
Ideally, it would be preferable to have informed consent from the subjects of the study, even if
there is no direct contact with them, but it is difficult to get it from a relatively large number of the
patients in a short time.  However, the investigator has taken all necessary measures to maintain
and assure the privacy, confidentiality and all benefits of the patients.  Data collectors were strictly
oriented, advised and supervised closely by the investigator on a daily basis.
Patients’ records are taken by data collectors from registry to a separate room where only the data
collectors and the instigator have access.  After the data are collected, the records are returned to
the registry and placed in their shelves without any interference of the routine function of the
center. In the data collection form no mention is made about the names of the patients, their
addresses, telephone number, the names of the providers or anything related to the study.
On the other side, the findings of the study are believed to benefit the patients if the facts include
medical follow-up on the behalf of thee patients; like oversight in care provision and application
of new knowledge to the patients care.  This can maximize the benefit and minimize the harm.
Ethical clearance for the study was obtained from University of Gondar and Addis Continental
Institute of Public Health. Letter of support was written to Addis Ababa Health Bureau which
gave permission for the study to be carried out in ZMH through a letter submitted to the
administration of the hospital. After permission was secured from the hospital administration, the
study was conducted between January and June 2009.
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V. Results
1. Results from quantitative study
A total of 1561 medical records of ART patients’ were assessed for data recorded as per ART
intake and follow-up forms.  1139 (73%) of them were under follow-up and treatment up to the
end of August 2007 and 228 (14.6%) were lost to follow-up. 128(8.2%) of them expired within the
twelve month period of the study while 66 (4.2%) were transferred out.  There were no transferred
in cases (figure 1).
The mean age of the study subjects was 35.6 years ranging between 16 and 88. The age group
between 26-35 years 741(475%) is the majority, followed by group 36-45 years, 415(26.6%).
Females accounted for 947(60.7%) and males 614(39.3%).  Three hundred thirty five (21.5%)
were single, 628(40.2%) married, 178(11.4%) divorce, 275(17.6%) widowed 81(5.2%) separated
and 64(4.1%) had no recorded status of marriage. About 230 (14.7%) of the eases were illiterate
and majority of them 525(33.6%) did not complete their high school education.  A vast majority of
cases 1521 (97.4%) had nothing recorded in their files about their occupation while 1539(98.6%)
did not had their incomes recorded (Table 1).
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Table 1. Socio-demographic Characteristics of the study population in Zawditu Memorial
Hospital ART Clinic Addis Ababa  September 2006-August 2007.
Variable Number Percent(%)
Sex Male 614 39.3%
Female 947 60.7%
Age (in years) 16-25 212 13.5%
26-35 741 47.5%
36-45 415 26.6%
46-55 140 9.0%
>55 53 3.4%
Marital Status Single 335 21.5%
Married 628 40.2%
Divorced 178 11.4%
Widowed 275 17.6%
Separated 81 5.2%
Missing 64 4.1%
Education Illiterate 230 14.7%
Grade 1-8 525 33.6%
Grade 9-12 466 29.9%
Above grade 12 136 8.7%
Missing 204 13.1%
Occupation Employed 22 1.4%
Daily laborer 1 0.1%
Unemployed 6 0.4%
Different
businesses
11 0.7%
Missing 1521 97.4%
Income class <150 Birr 10 0.6%
151-500 Birr 5 0.3%
501-1000 Birr 0 0.0%
Above 1000 Birr 7 0.4%
Missing 1539 98.6%
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Table 2 shows the completeness of information about patients on ART. Interestingly all essential
tests and measurements recommended for monitoring the progress of patients on ART are not
properly done. The missing values substantially increase as the patient progress in the treatment
program.
Parameters used for assessing quality of
ART patients monitoring Follow up visits
0 month
(Initiation of
ART) At 6 months At 12 months
Patient functionality status recorded 1533(98.2%0 1223(78.3%) 1154(73.9%)
Hemoglobin level recorded 1536(98.4%) 1073(68.7%) 483 (30.9%)
Total WBC recorded 1442(92.4) 1032(66.1%) 369 (23.6)
Lymphocytes count recorded 1431(91.7%) 1023(65.5%) 361 (23.1%)
Liver function test: ALT (IU/L)
recorded 1483 (95%) 1043(66.8%) 385(24.7%)
Liver function test: AST(IU/L)
recorded 1386 (88.8%) 1029(65.9%) 385(24.7%)
CD4 Count recorded 1556(997 %) 977 (62.6%) 434(27.8%)
Table 2. Record Completeness of the Study Population on ART in Zawditu Memorial Hospital
ART clinic Addis Ababa, Ethiopia, September 2006-August 2007
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Figure 1. shows the proportion of patients whose CD4 cell count was determined
with the declining pattern with increase in follow up time (from initiation to six months
and then to twelve months).
Figure 1. The proportion of study p0pulation whose CD4 was determined at interval of six
months in Zawditu Memorial Hospital ART clinic Addis Ababa; September 2006-August 2007.
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Figures 2 and 3 demonstrate the value of proper monitoring of test parameters in ART program.
For those patients with complete record of CD4 count at initiation, 6 months and 12 months a
trend analysis was done. As demonstrated in the figure 1, CD4 count showed substantial
increment as the follow progresses. A general linear model (GLM) for the repeated measure also
revealed that the increment was statistically significant (P<0.000).
Figure 1.
Table  2. Pattern of the mean CD4 cells count at baseline, at six and twelve months
after initiation of ART for those whose CD4 data were complete in the three points
in time.
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1 = base line          2= six month 3= 12 month
Figure 3.   General linear model analysis showed increment of CD4 cells on repeated
measurement at six and twelve months (p<o.ooo).
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Table  3. Determinants of Complete CD4 count among ART Patients in Zewditu
Memorial ART Clinic, Addis Ababa, September 2006-August 2007.
Variable Patients
with
complete
CD4 count
Patients without
complete CD4
count
Crude OR
(95% CI)
Adjusted OR
(95% CI)
Sex Female 173 774 1.109
(0.848 – 1.450)
0.936
0.653 – 1.342)
Male 103 511 1 1
Age (in years) 15 – 24 18 89 1 1
25 – 34 112 557 0.994
(0.576- 1.716)
1.022
(0.526 - 1.985)
35 – 44 93 414 1.111
(0.638 – 1.933)
1.022
(0.507 – 2.061)
45 – 54 41 161 1.259
(0.683 – 2.321)
1.301
(0.598 – 2.828)
>=55 12 64 0.927
(0.417 – 2.059)
1.537
(0.566 – 4.173)
Functional status
at initiation of
ART
Working 164 543 1 1
Ambulating 90 476 0.626
(0.471 – 0.833)
0.927
(0.636 – 1.354)
Bed-ridden 21 239 0.291
(0.180 – 0.470)
0.590
(0.304 – 1.143)
Functional status
at 6th month of
ART
Working 245 750 1 1
Ambulating 24 169 0.435
(0.277 – 0.683)
0.809
(0.403 – 1.621)
Bed-ridden 4 31 0.395
(0.138 – 1.130)
0.719
(0.133 – 3.889)
Functional status
at 12th month of
ART
Working 256 783 1 1
Ambulating 13 81 0.491
(0.269 – 0.897)
0.615
(0.249 – 1.519)
Bed-ridden 1 20 0.153
(0.020 – 1.145)
0.265
(0.027 – 2.629)
WHO Stage I 6 21 1 1
Ii 55 158 1.218
(0.468 – 3.175)
1.081
(0.356 – 3.288)
Iii 157 767 0.716
(0.285 – 1.804)
0.824
(0.279 – 2.435)
iv 58 339 0.599
(0.232 – 1.547)
1.014
(0.325 – 3.163)
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The qualitative study
The qualitative part of the study was included to complement the quantitative one by assessing
the perspectives of the health care providers regarding some of problems related to their
activities. For the purpose a structured close ended questionnaire was used to collect data. Ten
health providers; ART physicians, ART nurses and data clerks working in the ART clinic
participated in this study.
2. Results from the qualitative study.
Out of ten participants 4(40%) were males and 6(60%) were females. The group comprised
two ART physicians (20%), six ART nurses (60%) and two data clerks(20%). Eight (80%) of
them said they do not have refreshment courses on ART; 2(20%) said the working
environment is bad and 5(50%) said it is fair. Four (40%) mentioned lack of incentives while
two (20%) said there is lack of training on data recording and record keeping. Four (40%) had
training on the subject but other 4(40%) said it was not sufficient. Fifty percent of them stated
that they record all data in the files of each patient, Thirty percent record sometimes and
twenty percent of them said they are not recording. Fifty percent of them think there are
missing data in patients’ files while fifty percent said may be some data are missing. All know
the use of data recording and keeping in patient care and 7(70%) believe training on data
recording and keeping can have a positive contribution in improving their capacity of data
recording and keeping.
66.6% of them said they do not receive laboratory results in time; the reason as mentioned by
3(100%) of them is (especially for CD4 count), due to limited capacity of the CD4 cell count
machine. The other reason given is that some patients live out of Addis Ababa, some travel
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out of town for different purposes and do not have enough time to return to the clinic and do
the laboratory investigations in time.
All participants agree that these problems can be solved by involvement of the health care
providers, the hospital administration, Addis Ababa RHB/HAPCO and International Partners
working in this area.
The overall findings of the analysis can be summarized into three categories as causes for
significant number of missing data.
1. Non conducive working environment: high patient load on limited number of health care
providers per day, which does not always allow them to record routine clinical events and
laboratory results, lack of timely updating and refreshment courses, training on data
recording and record keeping and lack of incentives.
2. Limited capacity of the laboratory; especially the CD4 cell count machine with its
occasional malfunctioning.
3. Problems related to clients: some of them travel out of Addis Ababa or live out Addis
Ababa, others do not have time to wait to give and collect results or do when they want
thus contributing to the missing data records in their files ( annex 3).
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VI. Discussion
This study revealed the majority of medical records for patients on ART at the center include all
essential ART monitoring information and test results at the initial visit. However, the records fail
to maintain complete records of test results including CD4 count in subsequent visits. The
incompleteness gets worse from six months to twelve months follow up, this makes monitoring
and evaluation of the service and patient care difficult (24). Those with complete CD4 count in all
three visits show significant improvement as the patients stay longer on treatment, which is a good
sign that those who had complete data in the ART centre are responding to the treatment with
positive effect on the status of good health (32). Out of the selected patient characteristics
evaluated; improved functional status after initiation ART and the stage of the disease before ART
were found to be significantly associated with the likelihood of having a CD4 count in all visits.
The structure and quality of medical record has been a matter of clinical, administrative and legal
interest for many years. Medical records are now used not only for the primary, but also secondary
clinical purposes including reporting the activities of health institutions’ services, monitoring their
performances and research. So the need for standardization of medical records is increasingly
emphasized in modern health care system (9,48).
This study focused particularly on evaluating the medical record keeping practice, the use of CD4
cells in monitoring response to ART, and their proportion among patients who accessed to ART.
In a majority of cases, the trend of recording data has been good at the start of the HAART, but for
the variables that needed repeated determinations at interval of 6 months, there were significant
numbers of missing data which increase with time of determination.  This pattern of increasing of
missing data as time of follow-up increases is mostly observed for the following variables: body
weight, CD4 cell count, hemoglobin, White blood cells and their differential counts and liver
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function tests. These kinds of observations cast a serious doubt on the capacity of ART centre to
properly handle a program that is supposed to be running for the life of patients initiated on ART.
ART program is an expensive and if not monitored properly it could even cost more due to
development of resistance( 39,  40).
There are few studies that were conducted in Addis Ababa and Gondar.  In the study done in
Addis in two private medical centers on 33 patients who were started on HAART, 21.2% did not
have anything recorded in their files about the income status.  This outcome of the study is just a
trial with small number of participants, in a private setup and may not be comparable, with the
findings in this study, but shows something done in our country regarding record keeping problem
(46).
The second study was carried out in Gondar Hospital to improve clinical standards by setting up
clinical audit. The results of introduction of clinical audit into various departments of the Hospital
showed, after evaluation by assigned body, 20 audits were commenced, 7 were completed, 11
were under progress and two were awaiting analysis .With the audit introduction excellent clinical
practice has been highlighted; such as treatment of common pediatric emergencies and
documentation in patients’ records.  Such efforts, if continued, can increase the credibility and
effectiveness of the centers showing substantial improvement in the care for the patients as well as
patient satisfaction (47).
An effort was made to find out the reason why so many data were not recorded from the focal
person and staff members of the ART clinic. Several possible contributing factors were
mentioned: some related to patient load on health providers (over 150-200 patients seen daily),
higher turnover of professionals, limited capacity of the HIV laboratory for over a hundred
patients seeking to do laboratory investigation daily, lack of reagents or malfunctioning of CD4
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cell counting machine occasionally; so the results are not made available on time.  There are also
patient related factors as stated by the staff: patients may travel out of Addis or they may be living
out of Addis, some may forget or do not want to do laboratory investigations requested in time;
others could be busy with their activities and do not have time to go to laboratory and give sample
and wait for the results. Most of them do not want to tell their profession (occupation) and salaries
because of fear that they would be made to pay for the services they receive from the clinic.
However, there are also other factors related to health providers: forgetting to record the results
that are attached to the files: not writing down some clinical events (like when drugs are changed,
when patients encounter new events, OI, acute infections, etc) which can be helpful for the
patients’ follow-up as well as for communicating with other health providers. Maintaining a
complete record is especially helpful in facilities where staff turnover is high. Thus, complete
record keeping is not only essential for monitoring and research purpose only but it is absolutely
important for providing satisfactory clinical care of  ART patients no matter who is actually
providing the service at any given time.
In a study conducted on ARVs-naive patients who were started on HAART, the CD4 cells count
increased in a biphasic pattern sharp increase in the first phase and smaller increase in the second
phase which can be explained by several factors, but the most important one is the redistribution
of CD4 cells trapped in the lymphoid tissues to the blood infected (48). In this study, we were able
to demonstrate a significant increase in the CD4 count but further analysis on that line was not
complete because of missing values in the subsequent visits.  However, it was noted that the
increase in mean value of CD4 cell count in one year was comparable to that of Nigeria’s study
(45), a South African community-based ART study (33), Ethiopia’s study conducted in three
hospitals of Ministry of Defense (49 50). ) and Bangkok’s  study (51).
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VII.   Strengths and Limitations of the Study
A. Strengths: -
 The findings on medical data completeness with significant number of unrecorded data,
especially for several variables that needed repeated determination as tools of patient
follow  up and care at interval of six months can serve as alarming sign for future
corrective actions in terms of supervising and supporting the ART activities closely at the
site.
 The data completeness finding of the study carried out in one site can be used as starting
point for future large scale studies in this area by interested researchers.
 The use of CD4 cell count as a measure of the ART response in this study is among few
studies in the country and can serve as a piece of information for those who want to
conduct studies for monitoring the outcome of ART.
B. Limitations:
 The fact that the study is carried out in one site does not make it representative, although
the service of HAART in Zawditu Memorial Hospital ART Clinic is not limited to only
those living in Addis Ababa.
 The study focused on ART Clients for 12 months and it does not show the subsequent
changes that take place beyond 48 weeks in CD4 cells pattern and clinical response.
 The study did not include all dimensions of quality assessment of the ART service
because of time and financial constraints.
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VIII. Conclusion and Recommendations
A. Conclusion
 Although initiation of ART is done with good documentation of background information
and conducting essential clinical tests, such practice is not maintained in subsequent visits.
 The proportion of patients who had CD4 cells recorded in consecutive intervals of repeated
results has dropped from (99.7% to 27.8%).
 The mean CD4 cells count significantly increased from initiation, to 6 months, and to 12
months indicating a positive impact of ART on the immunity, and general health condition
of the patients.
.B. Recommendations
 There is urging need of strengthening the ART Service in the site and creating conducive
working atmosphere. Designing mechanisms of supporting health providers and assign
adequate number of health providers working in the ART Clinic to decrease work load so
that the whole activities being under taken can be effective in terms proper documentation
and monitoring to achieve the end outcome as expected through provision of ART. The
hospital administration, Addis Ababa Health Bureau/HAPCO and other stakeholders are
expected to take appropriate actions, using the health care providers willing to be part of
the solutions.
 Observations show that there is need of sustained ART and adherence counseling
provision before and after initiation of ART, to decrease the number of patients that fail to
do requested laboratory investigations in time. This can help the health care providers take
timely decisions in providing proper care for the patients.
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 The trainings and courses designed for the health providers must include topics on proper
medical data recording and record keeping. Periodic refreshing courses for health
professionals, incentives and other benefits can have positive result on the service. The
above mentioned recommendations are forwarded to the hospital administration, Addis
Ababa Health Bureau/HAPCO and International partners supporting the ART program in
the capital city.
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Data Collection form for assessment of completeness of ART patients’ records in and
changes in CD4 cell count in ZMH; Addis Ababa, September 2006- August 2007
Socio Demographic factors
S.No
1 Unique  Number
2 Age (years)
3 Sex 1. Male
2. Female
4 Marital Status 1. Single
2. Married
3. Divorced
4. Widowed
5. Separated
6. Not available
5 Educational Status 1. Illiterate
2. Grade 1-8
3. Grade 9-12
4. Grade 12 and above
5. Not available
6 Occupation 1. Employed
2. Daily Laborer
3. Unemployed
4. Others business (specify)
5. Not available
7 Income class birr 1. Less than 150
2. 150-500
3. 501-100
4. above 1000
5. Not available
8 Follow up 1. Regular
2. Irregular
9 Months on ART(1-12) 1. Number of months on ART
___________________
(Max 12 months)
S.N Clinical Data
10 Weight (Kg) 1. at 0 month __________
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2. at 6 months _________
3. at 12 months ________
4. not available  (missing) ______
11 Pregnancy 1. Yes
2. No
3. Not applicable
12 Functional status (WAB) 1.Working at month  at 0 mo.___
2.Ambulating at month  at 6 mo.__
3.Bed ridden at month  at 12 mo.__
13 Adverse Drug Reaction
(ADR)
(non – ARVs drugs)
1. Yes _____________
2. No ______________
3. If yes specify ______________
14 WHO stage of Disease I- IV: _______
15 TB Screen 1. TB positive
2. TB Negative
3. No(not tested)
16 TB Prophylaxis 1. On prophylaxis (IPT)
2. On Tb  treatment
3. Not on IPT
4. Not on TB treatment
17 Opportunistic Infection 1. TB only (any type)
2. TB and others
(specify________
3. Others (specify ) __________
4. No  OIs
18 OI Prophylaxis  CO-
trimoxazole (CPT)
1. Yes
2. No
3. If yes , adherence
1. Good  __________
2. Fair  ___________
3. Poor  ___________
4. Unknown(missing)
19 Other medication dispensed
(non-ARVs)
1. Yes
2. No
3. If yes,
No of drugs
_________
_________
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_________
20 Antiretroviral Drugs
(ARVS)
A. 1. D4T+3TC+NVP(1a)
2.  D4T+3TC+EFV(1b)
3. ZDV+3TC+NVP(1c)
4. ZDV+3TC+EFV(1d)
5. Others (specify
__________)
6. 2nd line (specify
__________)
7. Not available (missing)
B. Adherence;
1. Good  ___________
2. Fair  ____________
3. Poor  ____________
4. Unknown (missing)
21 ARVs Changed (?) 1. Yes
2. No
3. If yes, specify why (ADR,
others) specify _____________
S.No Laboratory Results
22 CD4 Cell count or Total
lymphocyte Count
1. at month 0 ___________
2. at month 6 ____________
3. at month 12 ___________
23 Hemoglobin (Gram %) 1. At month 0 ___________
2. At month 6 ____________
3. At month 12 ___________
24 White cells Count/mm3 A. Total 0 mo.____   /mm3 . 6 mon
.____ 12 mon. ______
Neutroph 0 mon.______% 6
mon._____ _______  / % 12  mon.
______%
Lympho  0 mon. ____ / % .0 mon.
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Data collector Signature
Supervisor Signature Date
____ %.
25 Liver function test IU/Litre 1. ALT U/L   0 mon. ______ 6
mon_____    .12 mon. _____
AST U/L 0 mon. _____   . 6
mon._______  12 mon._____
26 Final out come 1. Patient on follow – up
2. Patient lost to follow – up
3. patient died
4. patient transfer out
5. unknown (any other group)
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Questionnaire for the qualitative data collection of assessment of
completeness of ART patients’ records and changes in CD4 cell count in
ZMH, Addis Ababa September 2006-August 2007
1 Personal data
a. Sex _____
b. Age _____ Year
1. Male
2. Female
Code
2. Responsibility in Art clinic 1. ART physician and co coordinators
2. ART Physician
3. ART nurse coordinator
4. ARV  Prescriber nurse (HANS nurse)
5. ART nurse (ARV and adherence
counselor)
6. Data Clerk
7. Data manager
3. Do you have training or
refreshment course on ART
regularly?
1. Yes
2. No
3. Rarely
4. How is the working condition in
the clinic?
1. Good
2. Fair
3. Bad
5. If your answer is bad, why?
Because of:
1. high patient load /day & inadequate
health providers number
2. Inadequate supply of material
3. poor laboratory service
4. All of the above
6. What are the most difficult
problems that you face during
your routine activity?
1. Lack of training
2. Staff shortage
3. Poor working environment
4. Lack of supply
5. Lack of incentives.
7. During your ART training, were
there topics on data recording
and record keeping?
1. Yes
2. No
3. Insufficient (not enough)
8. Do you record all the data (clinical
and Laboratory) in the files of
each patient regularly?
1. Yes
2. No
3. Sometimes
9. If you answer is no, Why? 1. High patient load and no time to do
so
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Because of 2. forget to record
3. I did not have any training in
recording and record keeping
4. No need of daily recording
10. Do you think some data are
missing on patients records?
1. Yes
2. No
3. Maybe
11. Do you think ART patients’ data
recording in their files has any use
in their care and related
purposes?
1. Yes
2. No
12. What do you suggest to improve
the data recording and record
keeping?
1. Assign some other people to do the
job
2. Increase the number of well trained
health providers and reduce the work
load
3. Have training on data recording and
record keeping
4. Close supervision and support of the
ART service and health professional by
concerned body.
13. Do you receive laboratory results,
specially the CD4 cells count in
time?
1. Yes
2. No
3. Sometimes
14. If your answer is no, why?
Because:
1. No reagent
2. No enough laboratory technicians
3. Limited capacity of CD4 count
machine
4. Malfunctioning of the CD4 count
machine, sometimes.
15 Do patients give sample and
collect result in time?
1. Yes
2. No
16. If no, why? Because: 1. Some are living out of Addis and
others  travel out of Addis
2. some have no enough time to wait
and do the laboratory investigations
or come over on appointments
3. Some simply do not want to do so
4. Others do it when they want
17. What do you think are solutions? 1. Improve the laboratory capacity to
shorten waiting time for patients
2. Provide regular counseling of
patients on the use of doing the
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laboratory investigations in time.
3. 1 and 2
18. Who do you think is responsible
body to correct some of the
problems that the clinic is facing?
1. The health providers
2. The hospital administration
3. A.A RHB /HAPCO + Partners (other
stakeholders)
4. All the above.
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Annexes
Annex 1. CD4 cell count changes (µ/L) at  interval of six months among those  who had the
CD4 cells determined in Zawditu Memorial Hospital ART Clinic Addis Ababa, September 2006-
August 2007
Baseline 6 months 12 months
Range -----Number-----(%) Range-----Number-----(%) Range-----Number-----(%)
1-50             313         20.2% 1-50            22
2.2%
1-50            8                  1.8%
51-100         358 23.0% 51-100        85
8.7%
51-100        23                5.3%
101-150       343         22.0% 101-150      174
17.8%
101-150      59                13.6%
150-200       324         20.8% 151-200      174
17.8%
151-200 67                15.4%
201-250       119         7.6% 201-250      176
18.0%
201-250      72                16.6%
250-300       54           3.5% 251-300      115
11.8%
251-300      57                13.1%
351-400       12 0.7% 301-350       89           9.1% 301-350      56                12.9%
>400            12             0.8% 351-400       56           5.7% 351-400      30                6.9%
401-450       22           2.3% >400            62                14.3%
>450            64           6.6%
Missing         5              0.3% Missing       584
37.4%
Missing        1127           72.2%
CD4<200      1338        85.7% CD4<200      455
46.6%
CD4<200      277            63.8%
CD4>200 218        14.3% CD4>200       522
53.4%
CD4>200      157
36.2%
Mean CD4 cells------- 126 Mean CD4 cells--------231 Mean CD4 cells--------- --266
SD-----------------------+/_83.2 SD---------------------+125.7 SD--------------------------+143.3
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Annex 2.   Data Completeness Pattern of the Study population (N=1561), Recorded
and Missing data in ZMH ART Clinic, Addis Ababa September 2006-August 2007
Variables Total records Percent Missing data Percent
Age 1561 100% 0 0%
Sex 1561 100% 0 0%
Marital status 1497 95.9% 64 4.1%
Education 1357 86.9% 204 13.1%
Occupation 40 2.6% 1521 97.4%
Income class 22 1.4% 1539 98.6%
Follow up 1561 100% 0 0%
Months on ART 1561 100% 0 0%
Body weight
0 month 1530 98.0% 31 2.0%
6 months 1199 76.8% 362 23.2%
12 months 1101 70.5% 460 29.5%
Pregnancy (females’ total nr) 948 100% 0 0%
Pregnant 36 3.8%
Non-pregnant 912 96.2%
Functional status
0 month 1533 98.2% 28 1.8%
6 months 1223 78.3% 338 1.7%
12 months 1154 73.9% 407 26.1%
ADRs to non-ARV grugs 1561 100% 0 0%
WHO stage 1561 100% 0 0%
TB screen 1561 100% 0 0%
TB prophylaxis 1561 100% 0 0%
Opportunistic infection 1561 100% 0 0%
Opportunistic inf. Prophylaxis(CPT) 1561 100% 0 0%
Adherence 1231 80.4% 310 19.6%
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Non-ARV drugs dispensed 1561 100% 0 0%
ARV drugs 1559 99.9% 2 0.1%
ARV drugs changed? 1561 100 0 0%
CD4 count
0 month 1556 99.7% 5 0.3%
6 month 977 62.6% 584 37.4%
12 month 434 27.8% 1127 72.2%
Hemoglobin
0 month 1536 98.4% 25 1.6%
6 month 1073 68.7% 488 31.3%
12 month 483 30.9% 1078 69.1%
Total WBC
0 month 1442 92.4% 119 7.6%
6 month 1032 66.1% 529 33.9%
12 month 369 23.6% 1192 76.4%
Neutrophils(differential0
0 month 1431 91.7% 130 8.35
6 month 1026 65.7% 535 34.5%
12 month 367 23.5% 1194 76.5%
Lymphocytes(differential)
0 month 1431 91.7% 130 8.3%
6 month 1023 65.5% 538 34.5%
12 month 361 23.1% 1200 76.9%
Liver function test(ALT)
0 month 1483 95% 78 5%
6 month 1043 66.8% 518 33.2%
12 month 385 24.7% 1176 75.3%
Liver function test(AST)
0 month 1386 88.8% 175 11.2%
6 month 1029 65.9% 532 34.1%
12 month 385 24.7% 1176 75.2%
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Annex 3. Analysis of the qualitative data collected from the health care providers of ZMH ART
clinic
Ser.
No
Questionnaires Frequency Num
ber
Percent
1 Personal data 1.Male
2.Females
4
6
40%
60%
2 Responsibility in ART clinic 1.ART physician and coordinat
2.ART physician.
3.ART clinic head nurse
4.ARV prescriber nurse
5.ARTnurse
6.Data clerk
Total
1
1
1
3
2
2
10
10%
10%
10%
30%
20%
20%
100%
3 Do you have training or refreshment
courses on ART regularly?
1.Yes
2.No
3.Rarely
1
8
1
10%
80%
10%
4 How is the working condition in the
clinic?
1.Good
2.Fair
3.Bad
3
5
2
30%
50%
20%
5 If your answer is bad, why? 1. High patient load
& inadequate no. of h.
providers
2. Inadequate supply
of materials
3. Poor lab. Service
4. All of the above
2 100%
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6 What are the most difficult problems
that you face during your routine
activity?
1.Lack of training
2.Staff shortage
3.Poor working condition
4.Lack of supply
5.Lack of incentives
2
1
2
1
4
20%
10%
20%
10%
40%
7 During your ART training, were there
topics on data recording and record
keeping?
1.Yes
2.No
3.Insufficient
4
2
4
40%
20%
40%
8 Do you record all data in the files of
each patient regularly?
1.Yes
2.No
3.Sometimes
5
2
3
50%
20%
30%
9 If you answer no; why? 1.High patient load
2.Have no training on data
recording and keeping
1
1
50%
50%
10 Do you think some data are missing in
patients’ files?
1.yes
2.May be
5
5
50%
50%
11 Do you think ART patients’ data
recording has any use in their care and
related purposes?
1.Yes 10 100%
12 What do you suggest to improve the
data recording and record keeping?
1.Assign some other people to
do the job
2.Have training on data
recording and keeping
3.Close supervision and
support  of the service and
professionals
2
7
1
20%
70%
10%
13 Do you receive lab. Results in time? 1.Yes
2.No
3.Sometimes
2
1
6
20%
10%
60%
14 If your answer is no; why? 1.Limited capacity of the CD4
cell count machine
3 100%
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15 Do patients give samples and collect
results in time?
1.Yes
2.No
3.Sometimes
4
2
3
44.4%
22.2%
33.3%
16 If your answer is no; why? 1.Some live out of Addis
Ababa others travel out of
Addis
2.Some do not have ti me to
wait and do investigations
4
2
80%
20%
17 What do you think are solutions? 1&2.i.e;improve the lab.
capacity and regular
counseling of patients
9 100%
18 Who do you think is responsible body
to correct some of the problems the
clinic is facing?
All ; i.e the health providers,
hospital administration, A.A.
RHB/HAPCO & other partners
10 100%
